Title: Effect of once-yearly zoledronic acid on the spine and hip as measured by quantitative computed tomography: results of the HORIZON Pivotal Fracture Trial
Authors: Eastell, R ×
Lang, T
Boonen, Sofie
Cummings, S
Delmas, P D
Cauley, J A
Horowitz, Z
Kerzberg, E
Bianchi, G
Kendler, D
Leung, P
Man, Z
Mesenbrink, P
Eriksen, E F
Black, D M
HORIZON Pivotal Fracture Trial #
Issue Date: Jul-2010
Publisher: Springer International
Series Title: Osteoporosis International vol:21 issue:7 pages:1277-85
Abstract: Changes in bone mineral density and bone strength following treatment with zoledronic acid (ZOL) were measured by quantitative computed analysis (QCT) or dual-energy X-ray absorptiometry (DXA). ZOL treatment increased spine and hip BMD vs placebo, assessed by QCT and DXA. Changes in trabecular bone resulted in increased bone strength.
ISSN: 0937-941X
Publication status: published
KU Leuven publication type: IT
Appears in Collections:Gerontology and Geriatrics
Ecology, Evolution and Biodiversity Conservation Section
× corresponding author
# (joint) last author

Files in This Item:

There are no files associated with this item.

Request a copy


All items in Lirias are protected by copyright, with all rights reserved.

© Web of science